Latin Clinical Trial Center

Welcome to Latin Clinical Trial Center

Founded by Dr. Carlos A. Sariol -in August 2006, Latin Clinical Trial Center (LCTC) provides an attractive source for conducting phase I-IV clinical research studies funded by Pharmaceutical, Biotech Companies, Contract Research Organizations or NIH funded trials. By integrating a leading, private-practice physician network, comprehensive site management and a solid patient recruitment program; LCTC provides a broad range of services fundamental to executing clinical trials expeditiously and economically. Our goal is to assist pharmaceutical companies and C.R.Os to successfully bring new therapeutic options for several medical conditions to the marketplace by providing the highest quality and cost-effective Clinical Research Trials.
Learn More About Us

Our Facilities

Our network has capabilities to conduct Phase 1, 2, 3 or 4 studies including those that have PK samples at different time points. Our multiple investigators have been conducting studies for multiple years in many indications. Specialists in the community included Gastroenterology, Endocrinologist, Cardiologist, Rheumatologist, Gynecology, Ophthalmology as well as Internal Medicine. All of them have proved experience in their fields and work in well-established practices.

Puerto Rico Facilities

LCTCPR is a dedicated clinical research facility with capabilities to conduct Phase 1, 2, 3 or 4 studies including those that have PK samples at different time points.

Florida Facilities

LCTC has recently expand their facilities to Tamarac, Florida. Latin Clinical Trial Center Florida (LCTCFL) has been established since January 2023 through a partnership with East Florida Premium Medical Care (EFPMC).

New medicines continually

Founded by physicians in 2006, LCTC Inc., provides an attractive source for conducting phase II-IV clinical research funded by Pharmaceutical, Biotech Companies, Contract Research Organizations or
NIH funded trials.
LEARN MORE

Trials Status

INTERCEPT PHARMACEUTICALS, INC. (747-304)

A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects with […]

ELI LILLY (I8F-MC-GPGH)

A Randomized, Phase 3, Open-Label Trial Comparing the effect of LY3298176 versus Titrated Insulin Degludec on Glycemic Control in Patients […]

ELI LILLY (I4V-MC-JAJA)

A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients with Rheumatoid Arthritis

AURINIA (AUR-VCS_2016-02)

A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Orelvo (voclosporin) (23.7 mg Twice Daily) with Placebo in […]

ENANTA PHARMACEUTICALS, INC. (EDP-305)

A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 […]

NOVARTIS (CQAW039A2315)

A 2-treatment period, randomized, placebo-controlled, multicenter parallel-group study to assess the safety of QAW039 when added to existing asthma therapy […]
1 2 3 8
Founded by physicians in 2006, LCTC Inc., provides an attractive source for conducting phase III-IV clinical research funded by Pharmaceutical, Biotech Companies, Contract Research Organizations or NIH funded trials.
Latin Clinical Trial Center
1801 Ponce de Leon Ave,
Suite 205, San Juan, PR 00909
787-249-4763 (24/7)
787-985-9911
Fax: 787-982-7100
© 2023 Latin Clinical Trial Center. All Rights Reserved.
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram